+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Irritable Bowel Syndrome Drug"

Irritable Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Irritable Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 154 Pages
  • Global
From
Digestive Health Market By Type, By Form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Digestive Health Market By Type, By Form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 310 Pages
  • Global
From
Loading Indicator

The Irritable Bowel Syndrome (IBS) Drug market is a subset of the Gastrointestinal Drugs market. IBS drugs are used to treat the symptoms of IBS, a chronic disorder of the large intestine. These drugs are used to reduce abdominal pain, bloating, and diarrhea. Common IBS drugs include antispasmodics, antidiarrheals, and laxatives. Antispasmodics are used to reduce muscle spasms in the intestines, while antidiarrheals are used to reduce the frequency of bowel movements. Laxatives are used to soften stools and reduce constipation. The IBS Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Allergan, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. Other companies in the market include AbbVie, Daiichi Sankyo, Johnson & Johnson, Novartis, and Sanofi. Show Less Read more